First Midwest Bank Trust Division’s Novartis NVS Stock Holding History

First Midwest Bank Trust Division’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-2,475	Closed	-$213K	–	390
2019 Q1	$213K	Sell	2,475 -268	-10%	-$21.5K	0.03%	368
2018 Q4	$211K	Buy	2,743 +100	+4%	+$7.78K	0.03%	339
2018 Q3	$204K	Buy	+2,643	New	+$195K	0.03%	400

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

First Midwest Bank Trust Division's NVS Position: Q2 2019 in Review

First Midwest Bank Trust Division sold out of Novartis (NVS) in Q2 2019, closing a stake of 2,475 shares — an estimated $213K sold.

First Midwest Bank Trust Division first reported a position in NVS in Q3 2018 and held it in 3 quarters. The position peaked at $213K in Q1 2019. 1,094 funds tracked by Wall St. Rank hold NVS as of Q2 2019.

First Midwest Bank Trust Division reported no remaining Novartis position as of Q2 2019 after selling out during the quarter.
First Midwest Bank Trust Division sold 2,475 Novartis shares in Q2 2019, an estimated $213K.
First Midwest Bank Trust Division first reported a position in Novartis in Q3 2018 and held it in 3 quarters.
First Midwest Bank Trust Division's Novartis position peaked at $213K in Q1 2019.
1,094 funds tracked by Wall St. Rank held Novartis as of Q2 2019.

Based on First Midwest Bank Trust Division's 13F filing for Q2 2019, filed 23 Jul 2019.